AlphAIAlphAI — Financial news for AI agents
StockNASDAQ · US · USDHealthcare · Biotechnology

$BRTX

BioRestorative Therapies, Inc.

Price · $BRTXvia TradingView
AI sentiment · 7d1 articles
SEP 5net (bullish − bearish)SEP 11
Bullish
0
Neutral
0
Bearish
1
Insider · 30dAll trades →

No SEC Form 4 filings for $BRTX in the last 30 days.

See all $BRTX insider activity →
Top stories · $BRTXMore →
SEP 11·SEC EDGAR 8-KLow

BioRestorative Therapies, Inc. (BRTX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

BioRestorative Therapies, Inc. (BRTX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 4, 2026, BioRestorative Therapies, Inc. (the “ Company ”) received a notice of resignation from Mr. Silva from

SEP 3·orthospinenews.com

BioRestorative Therapies Announces Reverse Stock Split – Ortho Spine News

BioRestorative Therapies (BRTX) announced a 1-for-20 reverse stock split, effective September 7, 2026, to meet Nasdaq's $1 minimum bid price requirement. Trading will resume on September 8, 2026, under the same ticker (BRTX) with a new CUSIP. The split reduces outstanding shares from 27.6M to ~1.38M, with no change in ownership percentages.

SEP 1·SEC EDGAR 8-K

BioRestorative Therapies, Inc. (BRTX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

BioRestorative Therapies, Inc. (BRTX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 4.01 Changes in Registrant’s Certifying Accountant. Dismissal of CBIZ CPAs P.C. On August 28, 2026, BioRestorative Therapies, Inc. (the “ Company ”) dismissed CBIZ CPAs P.C. (“ CBIZ ”) as the Company’s independent registered public accounting firm, effective as of that date.

BRTX sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning BRTX (BioRestorative Therapies, Inc.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.

Recent BRTX coverage spans corporate actions and financial news.

What's driving BRTX

  • Potential departure and severance dispute may pressure BRTX stock.

    SEC EDGAR 8-K · Sep 11, 2026

  • The reverse split reduces share count ~20‑fold and should lift the share price above $1, potentially stabilizing the stock and avoiding delisting.

    orthospinenews.com · Sep 3, 2026

  • Leadership transition and auditor change may increase short‑term volatility and raise governance concerns.

    SEC EDGAR 8-K · Sep 1, 2026

  • Board investigation authorized and company reserved rights, creating uncertainty around whether BRTX must pay ~$2.85M severance and accelerate equity.

    SEC EDGAR 8-K · Jul 16, 2026

  • The filing is a corporate governance/compensation update that can affect near-term sentiment and future cash/stock compensation expectations, but it does not disclose operating or financial performance changes.

    SEC EDGAR 8-K · Jun 12, 2026

AlphAI scores every news story that mentions BRTX with an AI model for sentiment and relevance, and aggregates insider trades from BioRestorative Therapies, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $BRTX

Score
SEP 11$BRTXLowSEC EDGAR 8-K

BioRestorative Therapies, Inc. (BRTX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

BioRestorative Therapies, Inc. (BRTX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 4, 2026, BioRestorative Therapies, Inc. (the “ Company ”) received a notice of resignation from Mr. Silva from

1 min read
SEP 1$BRTXLowSEC EDGAR 8-K

BioRestorative Therapies, Inc. (BRTX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

BioRestorative Therapies, Inc. (BRTX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 4.01 Changes in Registrant’s Certifying Accountant. Dismissal of CBIZ CPAs P.C. On August 28, 2026, BioRestorative Therapies, Inc. (the “ Company ”) dismissed CBIZ CPAs P.C. (“ CBIZ ”) as the Company’s independent registered public accounting firm, effective as of that date.

1 min read
JUL 16$BRTXMedSEC EDGAR 8-K

BioRestorative Therapies, Inc. (BRTX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

BioRestorative Therapies, Inc. (BRTX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. false 0001505497 0001505497 2026-07-08 2026-07-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report:

4 min read
JUN 12$BRTXLowSEC EDGAR 8-K

BioRestorative Therapies, Inc. (BRTX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

BioRestorative Therapies, Inc. (BRTX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-99.1 5 ex99_1.htm EX-99.1 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (this “ Agreement ”) is made as of June 10, 2026 (the “ Effective Date ”), by and between BioRestorative Therapies, Inc., a Nevada corporation (the “ Company ”), and Francisco Silva (t

2 min read
JUN 12$BRTXMedSEC EDGAR 8-K

BioRestorative Therapies, Inc. (BRTX): Entry into a Material Definitive Agreement

BioRestorative Therapies, Inc. (BRTX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 5 ex10_1.htm EX-10.1 REVOLVING CREDIT AGREEMENT Execution Version REVOLVING LOAN AGREEMENT` This Revolving Loan Agreement (this “ Agreement ”) is dated as of June 10, 2026, between BioRestorative Therapies, Inc. (the “ Borrower ”), and the lender identified on the signatu

4 min read
MAY 27$BRTXHighAI 9/10rttnews.com

Kaos Capital Takes 4.9% Stake In BioRestorative Therapies; Stock Surges In Pre-Market

BioRestorative Therapies (BRTX) rose in pre-market after Kaos Capital disclosed a 4.9% stake acquired via open-market purchases and asked for an immediate meeting with the board to explore strategic options. The Miami-based activist firm, led by Adam Arviv, said shareholders are not realizing meaningful value and cited potential AI-related opportunities. BRTX closed at $0.24 Tuesday and traded at $0.39 pre-market.

4 min read

Related tickers

More in Biotechnology